Monogram Biosciences, Inc. - Initial Statement of Beneficial Ownership (3)
September 30 2008 - 8:38PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
SIEBEL KENNETH F
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
9/29/2008
|
3. Issuer Name
and
Ticker or Trading Symbol
Monogram Biosciences, Inc. [MGRM]
|
(Last)
(First)
(Middle)
C/O PRIVATE WEALTH PARTNERS LLC, 80 E SIR FRANCIS DRAKE BLVD., 4TH FLOOR
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
LARKSPUR, CA 94939
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
5516600
|
D
|
|
Common Stock
|
8103000
|
I
|
By Private Wealth Partners LLC
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
This statement is being filed by Kenneth F. Siebel with respect to shares of the issuer's common stock beneficially owned
directly and indirectly by Mr. Siebel, including shares of the issuer's common stock beneficially owned by Private Wealth
Partners LLC, a California limited liability company and a registered investment adviser ("IA"). Mr. Siebel controls IA by
virtue of Mr. Siebel's position as a majority managing member of IA. IA acts as investment advisor to PWP Partnership Fund,
LLC and manages discretionary client accounts that include shares of the issuer's common stock.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
SIEBEL KENNETH F
C/O PRIVATE WEALTH PARTNERS LLC
80 E SIR FRANCIS DRAKE BLVD., 4TH FLOOR
LARKSPUR, CA 94939
|
|
X
|
|
|
Signatures
|
/s/ Kenneth F. Siebel
|
|
9/30/2008
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jul 2023 to Jul 2024